Education
About Us
Working with TipRanks
Follow Us
Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)
:INDRAMEDCO
INDRAMEDCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹235.00 - ₹571.95
Previous CloseN/A
Volume350.29K
Average Volume (3M)30.17K
Market Cap
₹44.64B
Enterprise Value₹42.52B
Total Cash (Recent Filing)₹3.22B
Total Debt (Recent Filing)₹327.60M
Price to Earnings (P/E)27.7
Beta0.99
Next Earnings
Aug 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 13, 2024Dividend Yield0.93%
Share Statistics
EPS (TTM)4.47
Shares Outstanding91,673,000
10 Day Avg. Volume33,180
30 Day Avg. Volume30,168
Financial Highlights & Ratios
PEG Ratio4.35
Price to Book (P/B)7.62
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
INDRAMEDCO FAQ
What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?
Indraprastha Medical Corporation Limited lowest stock price was ₹235.00 and its highest was ₹571.95 in the past 12 months.
What is Indraprastha Medical Corporation Limited’s market cap?
Indraprastha Medical Corporation Limited’s market cap is ₹44.64B.
When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?
Indraprastha Medical Corporation Limited’s upcoming earnings report date is Aug 11, 2025 which is in 21 days.
How were Indraprastha Medical Corporation Limited’s earnings last quarter?
Indraprastha Medical Corporation Limited released its earnings results on May 16, 2025. The company reported ₹4.47 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.47.
Is Indraprastha Medical Corporation Limited overvalued?
According to Wall Street analysts Indraprastha Medical Corporation Limited’s price is currently Overvalued.
Does Indraprastha Medical Corporation Limited pay dividends?
Indraprastha Medical Corporation Limited pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.93%. See more information on Indraprastha Medical Corporation Limited dividends here
What is Indraprastha Medical Corporation Limited’s EPS estimate?
Indraprastha Medical Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indraprastha Medical Corporation Limited have?
Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding.
What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?
Indraprastha Medical Corporation Limited reported an EPS of ₹4.47 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.897%.
Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?
Currently, no hedge funds are holding shares in IN:INDRAMEDCO
Company Description
Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
Metropolis Healthcare Ltd.
―
PFIZER LIMITED
―